By delving into the targeted regulatory interactions among CKMT2-AS1, miR-142-5p, and IFITM3, the aim was to elucidate the molecular mechanisms through which CKMT2-AS1 influences the onset and progression of HCC. This evidence concerns the gene IFITM3 and hepatocellular carcinoma.